'Vanished' or 'hidden' prostate cancer? Men with negative biopsies during active surveillance have good outcomes November 20, 2020 Can early-stage prostate cancer "vanish" during follow-up? More likely the cancer is just "hidden"—either way, negative biopsies during active surveillance for prostate cancer are associated with excellent long-term outcomes, reports a study in The Journal of Urology, an Official Journal of the American Urological Association (AUA).Read the full article here https://medicalxpress.com/news/2020-11-hidden-prostate-cancer-men-negative.html. More information: Carissa E. Chu et al. The Clinical Significance of Multiple Negative Surveillance Prostate Biopsies for Men on Active Surveillance—Does Cancer Vanish or Simply Hide?, Journal of Urology (2020). DOI: 10.1097/JU.0000000000001339Source: Medical Xpress Prostate Cancer News
Can early-stage prostate cancer "vanish" during follow-up? More likely the cancer is just "hidden"—either way, negative biopsies during active surveillance for prostate cancer are associated with excellent long-term outcomes, reports a study in The Journal of Urology, an Official Journal of the American Urological Association (AUA).Read the full article here https://medicalxpress.com/news/2020-11-hidden-prostate-cancer-men-negative.html. More information: Carissa E. Chu et al. The Clinical Significance of Multiple Negative Surveillance Prostate Biopsies for Men on Active Surveillance—Does Cancer Vanish or Simply Hide?, Journal of Urology (2020). DOI: 10.1097/JU.0000000000001339Source: Medical Xpress
Complete the Survey
